Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab and Azathioprine in Ulcerative Colitis (UC-SUCCESS)
NCT00537316Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Jul 2007
- Primary completion
- Feb 2010
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in ulcerative colitis (UC), sponsored by Merck & Co.. Started Jul 2007; status: terminated.
02
Drugs
infliximab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00537316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537316.